mRNA |
GSK-1904529A |
GDSC1000 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
FGIN-1-27 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.7 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.023 |
0.7 |
mRNA |
palmostatin B |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
paclitaxel |
FIMM |
pan-cancer |
AAC |
-0.053 |
0.7 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |